Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023)

Pulse Biosciences (PLSE) recorded quarterly Debt Ratio of 0.93 in Q1 2023, up 10.9% quarter-over-quarter from 0.83 in Q4 2022.

Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023) Analysis & Trends

Pulse Biosciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.93 for Q1 2023.

In Q1 2023, Debt Ratio changed N/A year-over-year to 0.93; the TTM figure through Mar 2023 stood at 0.93 (changed N/A YoY), while the FY2022 annual figure was 0.83, changed N/A from the prior year.
Debt Ratio was 0.93 for Q1 2023 at Pulse Biosciences, up from 0.83 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.93 in Q1 2023 to a low of 0.51 in Q1 2021.
Historically, Debt Ratio has averaged 0.75 across 3 years, with a median of 0.79 in 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	0.34
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	0.32
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	0.03
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	0.05
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	0.36
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	0.20
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	0.48
10	Pulse Biosciences	1.68 Bn	1.68 Bn	-	-

Download Data